Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China
Featured articles
Articles
-
-
Stress granules: emerging players in neurodegenerative diseases
-
Inhibition of SOD1 trimerization is a novel drug target for ALS disease
-
Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patients
-
Progranulin deficiency in the brain: the interplay between neuronal and non-neuronal cells
-
Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
-
Measles-mumps-rubella vaccination timing and autism among young african american boys: a reanalysis of CDC data
-
A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States
-
Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
-
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Editor-in-Chief
Aims and Scope
Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.
Affiliated with
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 10.8
5-year Journal Impact Factor: 11.6
Source Normalized Impact per Paper (SNIP): 2.374
SCImago Journal Rank (SJR): 3.371Speed 2024
Submission to first editorial decision (median days): 7
Submission to acceptance (median days): 126Usage 2024
Downloads: 782,151
Altmetric mentions: 24,032